Waystar Holding Corp. Stock Price, News & Analysis

Waystar (NASDAQ:WAY) has announced a definitive agreement to acquire Iodine Software for a total enterprise value of $1.25 billion. The acquisition will be funded through a 50/50 mix of cash and stock, with Iodine shareholders receiving approximately 8% ownership of the combined company.

The strategic acquisition aims to enhance Waystar's AI capabilities in healthcare payments, expanding its total addressable market by more than 15%. The deal is expected to be immediately accretive to gross margin and adjusted EBITDA margin, with revenue growth and earnings benefits anticipated by 2027. The company has identified over $15 million in run-rate cost synergies to be realized within 18-24 months post-closing.

Additionally, Waystar reported preliminary Q2 2025 revenue of approximately $271 million, representing 15% year-over-year growth. The transaction is expected to close by year-end 2025.

Waystar Holding Corp. (Nasdaq: WAY), a healthcare payment software provider, has scheduled its Q2 2025 earnings release for July 30, 2025, after market close. The company will host a conference call at 4:30 p.m. Eastern Time on the same day to discuss the financial results.

Investors can access the live audio webcast through Waystar's investor relations website at investors.waystar.com/news-events/events. An archived version of the webcast will be available for those unable to attend the live event.

Waystar (WAY) released a Forrester Consulting study highlighting AI's critical role in healthcare revenue cycle management (RCM). The study reveals that 82% of healthcare leaders consider AI integral to RCM operations, with 70% marking it as a top priority. AI implementations are delivering significant performance improvements of 13-37% across key metrics including claim accuracy, denial prevention, and payment speed. Trust in AI has grown substantially, with 60% of decision-makers reporting increased confidence post-implementation. The majority of healthcare organizations prefer established RCM software partners for AI capabilities over new vendors, citing faster implementation and proven security. The study, based on over 300 healthcare leaders' responses, indicates a clear trend toward strategic AI adoption, particularly in payer-facing workflows.

Waystar Holding Corp (Nasdaq: WAY), a healthcare payment software provider, has appointed two distinguished leaders to its Board of Directors. Aashima Gupta, Global Director of Healthcare Strategy and Solutions at Google Cloud, brings expertise in AI strategy and digital healthcare transformation. She currently serves on multiple boards including Neogen and was named among Modern Healthcare's Top 10 Executives to Watch in 2024. Michael Roman, former Executive Chairman and CEO of 3M, joins with nearly 40 years of experience leading a $32 billion global technology company. Roman, who currently serves on Abbott Laboratories' board, brings strategic leadership and operational excellence, particularly notable given 3M's significant healthcare division which represents 25% of its revenue.

Waystar (Nasdaq: WAY), a healthcare payment software provider, has been recognized as a 2025-2026 Best Company to Work For by U.S. News & World Report. The company ranked in the top 6% among 5,000 evaluated public companies and within the top 25% in both the Health Care and Research sector and the West region.

The evaluation was based on six key factors: pay and benefits, work-life balance, job stability, physical and psychological comfort, belongingness, and career development. CEO Matt Hawkins highlighted the company's culture of innovation and commitment to simplifying healthcare payments for over one million providers nationwide. Waystar has also received recognition from Fortune's Great Place to Work®, Becker's Healthcare, and the Women Tech Council's Shatter List.

EQT has successfully completed a public offering of Waystar Holding Corp. (NASDAQ: WAY) common stock, generating total gross proceeds of $557.0 million. The offering included approximately 14.4 million shares, with underwriters fully exercising their option to purchase an additional 1.9 million shares. EQT sold about 6.2 million shares, receiving $239.6 million in gross proceeds, while retaining approximately 32.6 million shares. The remaining shares were sold by other stockholders. J.P. Morgan, Goldman Sachs & Co. LLC, and Barclays served as joint book-running managers. Waystar did not sell any shares or receive proceeds from this offering.

Waystar Holding Corp. (Nasdaq: WAY) has announced the pricing of a public offering where certain stockholders, including EQT AB, Bain Capital, and CPP Investments, will sell 12.5 million shares at $38.75 per share. The Selling Stockholders have also granted underwriters a 30-day option to purchase up to 1.875 million additional shares.

The offering, expected to close around May 16, 2025, is being led by J.P. Morgan, Goldman Sachs, and Barclays as joint lead book-running managers. Notably, Waystar itself is not selling any shares and will not receive any proceeds from this offering.

Waystar Holding Corp. (Nasdaq: WAY), a healthcare payments software provider, announced a proposed public offering of 12,500,000 shares of common stock by its major shareholders EQT AB, Bain Capital, LP, and Canada Pension Plan Investment Board. The Selling Stockholders will also grant underwriters a 30-day option to purchase up to 1,875,000 additional shares.

The offering will be led by J.P. Morgan, Goldman Sachs & Co. LLC, and Barclays as joint lead book-running managers. Importantly, Waystar itself is not selling any shares and will not receive any proceeds from the offering. The sale is subject to SEC registration statement effectiveness and other regulatory requirements.

Waystar (Nasdaq: WAY), a healthcare payment software provider, has been named Best Overall Healthcare Payments Solutions Provider by MedTech Breakthrough for the fourth consecutive year. The company's AI-powered platform, including Waystar AltitudeAI™, has demonstrated significant efficiency improvements, reducing denial appeal times by 70% and cutting denial-prevention workflows from three days to three minutes.

Waystar's recent achievements include ranking #1 in eight out of 18 AI categories by Black Book Market Research™, receiving recognition in two revenue cycle categories by Best in KLAS®, and being included in Forbes' inaugural Most Trusted Companies in America list. The company's software solutions serve over one million healthcare providers nationwide, focusing on reducing administrative waste and streamlining healthcare payments.